$RLAY insider trading

Over the last 12 months, Relay Therapeutics insiders reported no purchases and 9 sales totaling $7.2M across SEC Form 4 filings. 67% of the activity was filed under pre-arranged 10b5-1 trading plans.

$7.2M
9
4
67%
Side
$10K$100K$1.0M$10MJun '26JulAug
Bergstrom Donald A
Catinazzo Thomas
Rahmer Peter
Patel Sanjiv

All insider trades

Jul 28, 2026Catinazzo Thomas▼ Sale1,459$18.61$27K-0.9%
Jul 28, 2026Rahmer Peter▼ Sale748$18.61$14K-0.3%
Jul 28, 2026Bergstrom Donald A▼ Sale2,237$18.61$42K-0.5%
Jul 7, 2026Patel Sanjiv▼ Sale48,199$19.58$944K-7.3%
Jul 6, 2026Bergstrom Donald A▼ Sale8,660$18.71$162K-2.1%
Jul 6, 2026Catinazzo Thomas▼ Sale17,717$18.69$331K-10%
Jun 30, 2026Rahmer Peter▼ Sale50,000$19.09$955K-18.1%
Jun 22, 2026Catinazzo Thomas▼ Sale187,163$16.97$3.2M-51.3%
Jun 22, 2026Bergstrom Donald A▼ Sale93,456$16.94$1.6M-18.3%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $RLAY feed.

RLAY Insider Trading — Form 4 Buys & Sells | alphai